352 related articles for article (PubMed ID: 7824256)
1. [Oncogenes and tumor suppressor genes in the signal transduction pathways of growth factors].
Buday L
Orv Hetil; 1994 Nov; 135(47):2579-84. PubMed ID: 7824256
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
3. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
Bortner DM; Langer SJ; Ostrowski MC
Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
[TBL] [Abstract][Full Text] [Related]
4. Ras farnesyltransferase: a new therapeutic target.
Leonard DM
J Med Chem; 1997 Sep; 40(19):2971-90. PubMed ID: 9301658
[No Abstract] [Full Text] [Related]
5. Oncogenes, onco-suppressors, carcinogenesis and oral cancer.
Scully C
Br Dent J; 1992 Jul; 173(2):53-9. PubMed ID: 1386990
[TBL] [Abstract][Full Text] [Related]
6. Ras regulatory interactions: novel targets for anti-cancer intervention?
Prendergast GC; Gibbs JB
Bioessays; 1994 Mar; 16(3):187-91. PubMed ID: 8166672
[TBL] [Abstract][Full Text] [Related]
7. Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes.
Rosales C; Juliano R
Cancer Res; 1996 May; 56(10):2302-5. PubMed ID: 8625304
[TBL] [Abstract][Full Text] [Related]
8. Oncogenes and antioncogenes in human breast carcinoma.
Leslie KO; Howard P
Pathol Annu; 1992; 27 Pt 1():321-42. PubMed ID: 1346552
[No Abstract] [Full Text] [Related]
9. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
11. [Recent advances in gene change of pancreatic cancer].
Wang YY; Cui QC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
[TBL] [Abstract][Full Text] [Related]
12. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.
Lim KH; Counter CM
Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246
[TBL] [Abstract][Full Text] [Related]
13. Targeting RAS signalling pathways in cancer therapy.
Downward J
Nat Rev Cancer; 2003 Jan; 3(1):11-22. PubMed ID: 12509763
[TBL] [Abstract][Full Text] [Related]
14. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
15. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways in pancreatic cancer.
Reddy SA
Cancer J; 2001; 7(4):274-86. PubMed ID: 11561604
[TBL] [Abstract][Full Text] [Related]
17. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
He S; Dibas A; Yorio T; Prasanna G
Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor regulates protein kinase A activity in murine fibrosarcoma cells: differences between metastatic and nonmetastatic tumor cell variants.
Fishman D; Galitzki L; Priel E; Segal S
Cancer Res; 1997 Dec; 57(23):5410-5. PubMed ID: 9393768
[TBL] [Abstract][Full Text] [Related]
20. Ras farnesyltransferase inhibition: a novel and safe approach for cancer chemotherapy.
Nammi S; Lodagala DS
Acta Pharmacol Sin; 2000 May; 21(5):396-404. PubMed ID: 11324435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
